ArticleOncotarget2014
Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL.
Aneta Schieferdecker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
19 papers cite it
this paperpooled itcites it